Spironolactone Effect in Hepatic Ischemia/Reperfusion Injury in Wistar Rats
Authors:
- Julio César Jiménez PérezJPJulio César Jiménez Pérez
- Liliana Torres GonzálezLGLiliana Torres González
- Linda Elsa Muñoz EspinosaLELinda Elsa Muñoz Espinosa
- Marlene Marisol Perales QuintanaMQMarlene Marisol Perales Quintana
- Homero Zapata ChaviraHCHomero Zapata Chavira
- Francisco Javier Guzmán de la GarzaFGFrancisco Javier Guzmán de la Garza
- Paula Cordero PérezPPPaula Cordero Pérez
Open Access
- 21 December 2015
- journal article
- research article
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2016 (1) , 3196431
Abstract
Introduction. Ischemia/reperfusion (IR) injury, often associated with liver surgery, is an unresolved problem in the clinical practice. Spironolactone is an antagonist of aldosterone that has shown benefits over IR injury in several tissues, but its effects in hepatic IR are unknown. Objective. To evaluate the effect of spironolactone on IR‐induced damage in liver. Materials and Methods. Total hepatic ischemia was induced in rats for 20 min followed by 60 min of reperfusion. Spironolactone was administered and hepatic injury, cytokine production, and oxidative stress were assessed. Results. After IR, increased transaminases levels and widespread acute inflammatory infiltrate, disorganization of hepatic hemorrhage trabeculae, and presence of apoptotic bodies were observed. Administration of SPI reduced biochemical and histological parameters of liver injury. SPI treatment increased IL‐6 levels when compared with IR group but did not modify either IL‐1β or TNF‐α with respect to IR group. Regarding oxidative stress, increased levels of catalase activity were recorded in IR + SPI group in comparison with group without treatment, whereas MDA levels were similar in IR + SPI and IR groups. Conclusions. Spironolactone reduced the liver damage induced by IR, and this was associated with an increase in IL‐6 production and catalase activity.Keywords
This publication has 39 references indexed in Scilit:
- Activation of the aldosterone/mineralocorticoid receptor system and protective effects of mineralocorticoid receptor antagonism in retinal ischemia-reperfusion injuryExperimental Eye Research, 2012
- Vascular clamping in liver surgery: physiology, indications and techniquesAnnals of Surgical Innovation and Research, 2010
- Efficacy of Spironolactone Therapy in Patients With True Resistant HypertensionHypertension, 2010
- Endocannabinoids and cannabinoid receptors in ischaemia–reperfusion injury and preconditioningBritish Journal of Pharmacology, 2008
- Renal ischemia-reperfusion injury is prevented by the mineralocorticoid receptor blocker spironolactoneAmerican Journal of Physiology-Renal Physiology, 2007
- Delivery of antioxidative enzyme genes protects against ischemia/reperfusion–induced liver injury in miceLiver Transplantation, 2006
- Past and future approaches to ischemia-reperfusion lesion associated with liver transplantationLife Sciences, 2006
- Cardioprotective Effects of Eplerenone in the Rat HeartHypertension, 2006
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999
- Interleukin-6 protects liver against warm ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodentHepatology, 1997